The tweet was deleted by the author.
But we saved everything 🙂.
PDS Biotechnology has published its financial results for the third quarter. The announcement provides investors and stakeholders with the latest overview of the company’s fiscal position and operational performance for the period.
Although full details are available on the company’s website, PDS Biotechnology’s disclosure underscores a commitment to transparency with regular updates on business performance.
View post on X Loading...
Earlier this year, PDS Biotechnology expanded its leadership team by naming John Dawson, Deborah Ramsdell, and Bruce Wendel as new board members, adding industry expertise to its board of directors. Details of these appointments are available in the company’s board announcement. The appointments followed the company’s practice of regular public disclosures.